Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Kiora Pharmaceuticals's profit margin for the twelve months ending Mar 31, 2025 was -60257.3%. For fiscal 2024 it was 22.4%, against -56901.7% the year before. The highest annual figure on record is 22.4% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 22.4% | +56924.1 |
| FY2020 | Dec 31, 2020 | -56901.7% | −56637.4 |
| FY2019 | Dec 31, 2019 | -264.2% | +390.0 |
| FY2018 | Dec 31, 2018 | -654.2% | +2589.3 |
| FY2017 | Dec 31, 2017 | -3243.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | -11108.2% | −10115.0 |
| Q1 FY2024 | Mar 31, 2024 | 84.1% | +1232.9 |
| Q4 FY2020 | Dec 31, 2020 | -9831.6% | −9614.5 |
| Q1 FY2019 | Mar 31, 2019 | 32.4% | +5575.4 |
| Q3 FY2018 | Sep 30, 2018 | -993.3% | +1250.2 |
| Q2 FY2018 | Jun 30, 2018 | -1148.8% | +433.4 |
| Q1 FY2018 | Mar 31, 2018 | -217.1% | – |
| Q3 FY2017 | Sep 30, 2017 | -5543.0% | – |
| Q2 FY2017 | Jun 30, 2017 | -2243.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -1582.2% | – |
See a number that looks wrong?